JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
SGMO - Sangamo Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary SGMO Stock
Financials
Financials SGMO Stock
Loading...
Loading...
Income Statement
Income Statement SGMO Stock
Balance Sheet
Balance Sheet SGMO Stock
Cash Flow Statement
Cash Flow Statement SGMO Stock
Loading...
Loading...
SGMO Financials - Sangamo Therapeutics Income & Cash Flow | Ledgeburg
Home
Stocks
Sangamo Therapeutics, Inc. (SGMO)
Financials
Financials of SGMO
Loading...
Loading...
Loading...
Loading...
Revenue
$39.552M
Operating Income
$-121.239M
Net Income
$-122.932M
Share Count (Basic)
280.193M
Operating Cash Flow
$-97.208M
Free Cash Flow
$-97.31M
Cash And Short-Term Equivalents
$20.948M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
50M
100M
150M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
5M
10M
15M
20M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-250M
-200M
-150M
-100M
Annual
Quarterly
Margins
Gross
Operating
Net
-300%
-250%
-200%
-150%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-35M
-30M
-25M
-20M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-6000%
-4000%
-2000%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26